Source comparison
Thymosin Alpha-1 20s Age-Specific Protocol: Comparison by Age Group
20–29 years 0.8–1.2mg Once weekly 60–75% of peak 20–30% faster than age 40+ Every 4–6 weeks Lower doses exploit higher baseline thymic function. Avoid over-supplementation 30–39 years 1.2–1.6mg Once to twice weekly 45–60% of peak Moderate clearance Every 6–8 w
This comparison does not assign a generated winner or score.
- 20–29 years
- 0.8–1.2mg
- Once weekly
- 60–75% of peak
- 20–30% faster than age 40+
- Every 4–6 weeks
- Lower doses exploit higher baseline thymic function. Avoid over-supplementation
- 30–39 years
- 1.2–1.6mg
- Once to twice weekly
- 45–60% of peak
- Moderate clearance
- Every 6–8 weeks
- Transition zone. Dosing depends on individual immune markers
- 40–49 years
- 1.6mg
- Twice weekly
- 30–45% of peak
- Standard clearance
- Every 8–12 weeks
- Thymic involution accelerates. Higher doses compensate for reduced output
- 50+ years
- 1.6–3.2mg
- <30% of peak
- Slower clearance
- Every 12 weeks
- Maximum compensation protocols. Higher cumulative weekly dose supports depleted thymic reserve